Hisamitsu gains first US prescription approval
This article was originally published in Scrip
The US FDA has approved an ANDA for a transdermal fentanyl product manufactured by Hisamitsu, marking the first approval of a prescription product in the US for the Japanese firm.
You may also be interested in...
Novel antifungal T-2307, discovered by FUJIFILM Toyama, works by selectively disrupting mitochondrial function. Excelra and Maruho team up to repurpose existing drugs.
Diversified Japanese giant to launch tender for Danish transplant drug specialist as it looks to build US operations for health care business. Lundbeck and Novo Nordisk among investors that will see an exit.